Progeny 3 »

Crinetics Pharmaceuticals In shares owned by Progeny 3

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Progeny 3 from 13F filings

Historical chart of Progeny 3 investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Progeny 3 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Progeny 3

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 24k 46.55

More positions owned by Progeny 3

Cameco Corporation (CCJ)
Acuren Corporation (TIC)
Interactive Brokers Group In Com Cl A (IBKR)
Api Group Corp Com Stk (APG)
Ss&c Technologies Holding (SSNC)
Ishares Tr Core S&p500 Etf (IVV)
Gfl Environmental Sub Vtg Shs (GFL)
Alliance Resource Partners L Ut Ltd Part (ARLP)
PAR Technology Corporation (PAR)
Martin Marietta Materials (MLM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
MPLX Com Unit Rep Ltd (MPLX)
Enterprise Products Partners (EPD)
Daktronics (DAKT)
Sixth Street Specialty Lending (TSLX)

View all positions for Progeny 3

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Henderson Group
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In